The FDA is demanding e-cigarette makers come up with a plan to keep vapes away from minors. If manufacturers and retailers can’t do so in 60 days, the FDA has threatened to pull flavored products off the market. The agency also issued warning letters to more than 1,100 retailers, including Walgreens, 7-Eleven, and Circle K, for selling e-cigarettes to teens. (New York Times)
Cigna has launched a venture fund with $250 million to invest in startups. The insurer is looking to back healthcare companies that are working to improve quality, affordability, and choice and give patients more simplicity. Cigna Ventures is focused on three areas: insights and analytics, digital health and retail, and care delivery and management. (Bloomberg)
Takeda is closing its Chicago operations in the lead up to its merger with Shire. The company is cutting 1,000 jobs in the Windy City and focusing its U.S. presence in Boston, where Shire is based. (Endpoints News)
Teva is holding off launching an opioid addiction generic until a court resolves a case regarding a generic rival. Indivior, the maker of opioid-addiction treatment Suboxone Film, is in a legal battle with an Indian drugmaker that wants to relaunch a cheaper version of the drug in the U.S. (Reuters)
ICR has acquired Continuum Health Communications as part of its growth plan following backing from Investcorp. Continuum founder and CEO Terri Clevenger is joining ICR as a managing director. (MM&M)
